These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15359829)

  • 1. [Clinical management of asymptomatic HCV carriers].
    Nakamura I; Ochiai K; Imawari M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):396-9. PubMed ID: 15359829
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical, virologic and pathologic features of asymptomatic hepatitis C virus carriers].
    Shindo M; Okuno T
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):376-80. PubMed ID: 15359825
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H; Iwasaki Y; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract]   [Full Text] [Related]  

  • 4. Should we treat HCV carriers with normal ALT levels? The '5Ws' dilemma.
    Puoti C; Guarisco R; Spilabotti L; Bellis L; Mitidieri Costanza O; Dell' Unto O; Elmo MG
    J Viral Hepat; 2012 Apr; 19(4):229-35. PubMed ID: 22404720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis C and alcohol].
    Perlemuter G
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B105-11. PubMed ID: 12180277
    [No Abstract]   [Full Text] [Related]  

  • 6. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels.
    Alberti A
    J Hepatol; 2005 Feb; 42(2):266-74. PubMed ID: 15664254
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatitis C in childhood--natural history and therapy].
    Nagata I; Murakami J; Okamoto M; Iitsuka T; Kanzaki S; Shiraki K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):634-9. PubMed ID: 15359875
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical guidelines of diagnosis and treatment of hepatitis C].
    Rev Gastroenterol Mex; 2007; 72(2):177-91. PubMed ID: 17966381
    [No Abstract]   [Full Text] [Related]  

  • 10. Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.
    Di Bisceglie AM; Thompson J; Smith-Wilkaitis N; Brunt EM; Bacon BR
    Hepatology; 2001 Mar; 33(3):704-7. PubMed ID: 11230751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiviral therapy of hepatitis C].
    Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maximizing the benefits of antiviral therapy for HCV: the advantages of treating side effects.
    Gish RG
    Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):xxiii-xxiv. PubMed ID: 15081104
    [No Abstract]   [Full Text] [Related]  

  • 13. HCV carriers with normal alanine aminotransferase levels: healthy persons or severely ill patients? Dealing with an everyday clinical problem.
    Puoti C; Bellis L; Guarisco R; Dell' Unto O; Spilabotti L; Costanza OM
    Eur J Intern Med; 2010 Apr; 21(2):57-61. PubMed ID: 20206870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential diagnosis between asymptomatic HCV carriers and previously infected patients with anti-HCV antibody in general clinic setting].
    Yasuda K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):391-5. PubMed ID: 15359828
    [No Abstract]   [Full Text] [Related]  

  • 15. A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase.
    Okanoue T; Makiyama A; Nakayama M; Sumida Y; Mitsuyoshi H; Nakajima T; Yasui K; Minami M; Itoh Y
    J Hepatol; 2005 Oct; 43(4):599-605. PubMed ID: 16024129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Should we treat cirrhosis in hepatitis C carriers with antiviral agents?].
    Brenard R; Closon ML; Fevery J; Hautekeete M
    Rev Med Brux; 1999 Feb; 20(1):A50. PubMed ID: 10091538
    [No Abstract]   [Full Text] [Related]  

  • 17. Sustained virological response following extremely short antiviral treatment in selected HCV carriers with persistently normal ALT.
    Puoti C; Guarisco R; Spilabotti L; Bellis L
    Dig Liver Dis; 2010 Oct; 42(10):745. PubMed ID: 20303840
    [No Abstract]   [Full Text] [Related]  

  • 18. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.
    Bizollon T; Palazzo U; Ducerf C; Chevallier M; Elliott M; Baulieux J; Pouyet M; Trepo C
    Hepatology; 1997 Aug; 26(2):500-4. PubMed ID: 9252166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing hepatitis C infection in HIV-positive patients.
    Craven DE; Nunes DP
    AIDS Clin Care; 2000 Sep; 12(9):71-5, 78. PubMed ID: 12170952
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
    Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
    J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.